2024 annual financial data
Atrium Therapeutics 2024 Operating margin
Direct answer
Operating margin was -3,477.43%.
Operating income was -378,936,000 USD and net income was -322,302,000 USD.
Operating cash flow was -300,870,000 USD.
Get free Atrium Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,897,000 USD
- Operating income
- -378,936,000 USD
- Net income
- -322,302,000 USD
- Operating cash flow
- -300,870,000 USD